What do systematic reviews say?

Summary of findings table ‐ Exercise plus usual pharmacological care vs another intervention (education, joint aids, or relaxation) plus usual pharmacological care

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 17 participants
  Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

It is very uncertain whether summary of findings table ‐ Exercise plus usual pharmacological care changes withdrawals due to any reason compared with placebo plus usual pharmacological care (very low certainty).

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  RR 2.73 [0.34, 22.16]
  1 study · 21 participants
  Very low

Summary of findings table ‐ Exercise plus usual pharmacological care vs usual pharmacological care alone

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 104 participants
  Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs usual pharmacological care alone

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 96 participants
  Low

Autologous blood or PRP vs placebo at 3 months' follow‐up

• Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 523 participants
  Moderate

Autologous blood or PRP vs placebo at 3 months' follow‐up

• Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 502 participants
  Moderate

Autologous blood or PRP vs placebo at 3 months' follow‐up

It is very uncertain whether autologous blood or PRP changes treatment success (> 25% improvement in pain or function) compared with placebo at 3 months' follow‐up (very low certainty).

• Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
  RR 1 [0.83, 1.19]
  4 studies · 372 participants
  Very low

Autologous blood or PRP vs placebo at 3 months' follow‐up

• Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Autologous blood or PRP vs placebo at 3 months' follow‐up

• Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Autologous blood or PRP vs placebo at 3 months' follow‐up

It is very uncertain whether autologous blood or PRP changes withdrawal due to adverse events  compared with placebo at 3 months' follow‐up (very low certainty).

• Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
  RR 0.32 [0.03, 2.92]
  1 study · 80 participants
  Very low

Autologous blood or PRP vs placebo at 3 months' follow‐up

Autologous blood or PRP showed no clear difference in adverse events (pain and swelling at injection site and limitation… compared with placebo at 3 months' follow‐up (low certainty).

• Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
  RR 1.14 [0.76, 1.72]
  5 studies · 425 participants
  Low

Therapeutic ultrasound vs placebo

• Electrotherapy modalities for rotator cuff disease 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 61 participants
  Low

Therapeutic ultrasound vs placebo

• Electrotherapy modalities for rotator cuff disease 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 61 participants
  Low

Therapeutic ultrasound vs placebo

The review found no eligible studies for this question.

• Electrotherapy modalities for rotator cuff disease 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Therapeutic ultrasound vs placebo

Therapeutic ultrasound may leads to higher global assessment of treatment success compared with placebo (low certainty).

• Electrotherapy modalities for rotator cuff disease 2016 · Cochrane Headline outcomes only
  RR 1.75 [1.21, 2.53]
  1 study · 61 participants
  Low

Therapeutic ultrasound vs placebo

• Electrotherapy modalities for rotator cuff disease 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 61 participants
  Low